Study of EXPAREL in Patients Undergoing Breast Augmentation
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 24
Summary
- Conditions
- Mammoplasty
- Postoperative Pain
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Only males
Description
Each subject underwent bilateral augmentation mammoplasty and received the same dose of EXPAREL. This primary objective of this study was to assess the efficacy of EXPAREL when administered via infiltration versus instillation as part of bilateral augmentation mammoplasty. The secondary objectives w...
Each subject underwent bilateral augmentation mammoplasty and received the same dose of EXPAREL. This primary objective of this study was to assess the efficacy of EXPAREL when administered via infiltration versus instillation as part of bilateral augmentation mammoplasty. The secondary objectives were to further assess other efficacy measures and the safety profile of EXPAREL.
Tracking Information
- NCT #
- NCT01582490
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Daniel Del Vecchio, MD Steward Research
Get Well Soon